Overview

A Study Assessing the Safety and Pharmacokinetic Profile of Modified Release Formulations of Tolcapone

Status:
Completed
Trial end date:
2018-10-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the pharmacokinetic profiles of tolcapone in healthy subjects after administration of one or two oral doses of multiple modified release prototype formulations.
Phase:
Phase 1
Details
Lead Sponsor:
Corino Therapeutics, Inc.
Collaborator:
Quotient Sciences
Treatments:
Tolcapone